Stay updated on Nivolumab for ALK+ ALCL: Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.
Latest updates to the Nivolumab for ALK+ ALCL: Clinical Trial page
- Check5 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4.SummaryDifference0.1%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedLocations section updated to include Val De Marne as a study site. Page revision updated to v3.3.3.SummaryDifference0.2%
- Check55 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this appears to be a backend/formatting update with no impact on study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check62 days agoChange DetectedThe government funding/operating status notice and links (cc.nih.gov, opm.gov) at the top of the page have been removed.SummaryDifference0.4%
- Check76 days agoChange DetectedThe new screenshot appears to replicate the study record with formatting adjustments only; core content such as the study title, design, eligibility criteria, interventions, endpoints, and locations is unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check105 days agoChange DetectedUpdated core content with a government funding notice and NIH Clinical Center operating status, and bumped software version from v3.1.0 to v3.2.0.SummaryDifference3%
Stay in the know with updates to Nivolumab for ALK+ ALCL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.